LIVE

ScienceCan engineering solve the forever chemical problem?MarketsBest Credit Cards for Costco – Its Own Card Wins Only at the Pump MarketsYour Gut Sells Low and Buys High – Write Your Investing Rules Down First MarketsInvesting Isn’t Gambling – Hold Index Funds for Decades and Cap Bets at 5%MarketsBest Business Credit Cards for Freelancers & Side Hustlers – No Fee, No LLC Needed MarketsBest American Express Cards – Match the Card to Where You Spend Most WorldMarco Rubio weighs leaving Trump administration after midterm defeat, reports say - Ynetnews MarketsChimera sees agency returns at 16%-17% as Prism securitization expands platform integration MarketsEvergy raises 2026 adjusted EPS guidance to $4.35-$4.50 amid 1.4-gigawatt Digital Realty LOI LocalNevada Question 6 projected to pass, adding abortion rights to state constitution - KSNV BusinessOpaleye Management, a 10% owner, buys $33,019 of Grace Therapeutics stock BusinessADMA Biologics CEO Adam Grossman sells $1.76M in shares BusinessWhite Mountains subsidiary sells $76.4 million in MediaAlpha stock BusinessMetallus director Ronald Rice buys $166,100 in company shares LocalLiberal campaign bus crashes into shop awning on its first outing of Victorian election campaign BusinessINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Alphabet Inc. of Class Action Lawsuit and Upcoming Deadlines - GOOG BusinessINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ethos Technologies Inc. - LIFE BusinessPhase II Study of Ivonescimab in the Perioperative Setting for Resectable NSCLC Published in Nature Medicine MarketsFive9 anticipates at least 75% AI revenue growth in 2026 while planning $325M Level AI acquisition MarketsTrump-backed World Liberty Financial launches WLFI token buyback program ScienceHidden ecological risk from overlooked invasive crayfish species LocalC Sadanandan possible contender for Union berth after George Kurien’s exit - The New Indian Express BusinessPhilippines Q2 GDP revised upwards to 2.4%LocalCapreit expects peak-lease drag to last 15-17 months while planning $1.2B 2026 mortgage refinancings MarketsGildan expects $5.4B-$5.5B 2026 revenue amid macro shift, withdraws 2026-2028 objectives and forecasts $700M-$750M free cash flowTRENDING TICKERS: $CRWD $ASTS $FLNC $APP $VEEV $NTAP $EL $CCB $GIL $EG $LINC $NIQ $BULL $OI $DAVA $QBTS $RMNI $NOW $BETR $IQMX $NCPL $YRD $DUOL $BAC $BIDU $MSTR $PRAA $RHI $YFOR $QFINScienceCan engineering solve the forever chemical problem?MarketsBest Credit Cards for Costco – Its Own Card Wins Only at the Pump MarketsYour Gut Sells Low and Buys High – Write Your Investing Rules Down First MarketsInvesting Isn’t Gambling – Hold Index Funds for Decades and Cap Bets at 5%MarketsBest Business Credit Cards for Freelancers & Side Hustlers – No Fee, No LLC Needed MarketsBest American Express Cards – Match the Card to Where You Spend Most WorldMarco Rubio weighs leaving Trump administration after midterm defeat, reports say - Ynetnews MarketsChimera sees agency returns at 16%-17% as Prism securitization expands platform integration MarketsEvergy raises 2026 adjusted EPS guidance to $4.35-$4.50 amid 1.4-gigawatt Digital Realty LOI LocalNevada Question 6 projected to pass, adding abortion rights to state constitution - KSNV BusinessOpaleye Management, a 10% owner, buys $33,019 of Grace Therapeutics stock BusinessADMA Biologics CEO Adam Grossman sells $1.76M in shares BusinessWhite Mountains subsidiary sells $76.4 million in MediaAlpha stock BusinessMetallus director Ronald Rice buys $166,100 in company shares LocalLiberal campaign bus crashes into shop awning on its first outing of Victorian election campaign BusinessINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Alphabet Inc. of Class Action Lawsuit and Upcoming Deadlines - GOOG BusinessINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ethos Technologies Inc. - LIFE BusinessPhase II Study of Ivonescimab in the Perioperative Setting for Resectable NSCLC Published in Nature Medicine MarketsFive9 anticipates at least 75% AI revenue growth in 2026 while planning $325M Level AI acquisition MarketsTrump-backed World Liberty Financial launches WLFI token buyback program ScienceHidden ecological risk from overlooked invasive crayfish species LocalC Sadanandan possible contender for Union berth after George Kurien’s exit - The New Indian Express BusinessPhilippines Q2 GDP revised upwards to 2.4%LocalCapreit expects peak-lease drag to last 15-17 months while planning $1.2B 2026 mortgage refinancings MarketsGildan expects $5.4B-$5.5B 2026 revenue amid macro shift, withdraws 2026-2028 objectives and forecasts $700M-$750M free cash flowTRENDING TICKERS: $CRWD $ASTS $FLNC $APP $VEEV $NTAP $EL $CCB $GIL $EG $LINC $NIQ $BULL $OI $DAVA $QBTS $RMNI $NOW $BETR $IQMX $NCPL $YRD $DUOL $BAC $BIDU $MSTR $PRAA $RHI $YFOR $QFIN

Skip to content

I Built My Identity Around My Career, Then Illness Took It Away. Here’s What I Learned About Purpose.

Source: Entrepreneur · Nov 06, 2026 00:00 UTC

The Quick Take

A title can disappear overnight, but the skills beneath it don’t. Three questions to identify the strengths that carry over to whatever comes next.

Read the full story at Entrepreneur →

Ground Level News aggregates headlines from public feeds. This page shows a short summary only; the full article and all rights belong to Entrepreneur.

Related

Opaleye Management, a 10% owner, buys $33,019 of Grace Therapeutics stock

All News · 17m ago

ADMA Biologics CEO Adam Grossman sells $1.76M in shares

All News · 17m ago

White Mountains subsidiary sells $76.4 million in MediaAlpha stock

All News · 17m ago

Metallus director Ronald Rice buys $166,100 in company shares

All News · 17m ago